These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2839917)

  • 21. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3.
    Hibberd PL; Tolkoff-Rubin NE; Cosimi AB; Schooley RT; Isaacson D; Doran M; Delvecchio A; Delmonico FL; Auchincloss H; Rubin RH
    Transplantation; 1992 Jan; 53(1):68-72. PubMed ID: 1310173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG
    Clin Infect Dis; 1996 Aug; 23(2):292-7. PubMed ID: 8842266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
    Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
    Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.
    Grundy JE; Lui SF; Super M; Berry NJ; Sweny P; Fernando ON; Moorhead J; Griffiths PD
    Lancet; 1988 Jul; 2(8603):132-5. PubMed ID: 2899189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-transmitted cytomegalovirus infections: significance and control.
    Tegtmeier GE
    Vox Sang; 1986; 51 Suppl 1():22-30. PubMed ID: 3017003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppression.
    Johnson PC; Lewis RM; Golden DL; Oefinger PE; Van Buren CT; Kerman RH; Kahan BD
    Transplantation; 1988 Jan; 45(1):116-21. PubMed ID: 2827353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donated organ as a source of cytomegalovirus in orthotopic liver transplantation.
    Sutherland S; Bracken P; Wreghitt TG; O'Grady J; Calne RY; Williams R
    J Med Virol; 1992 Jul; 37(3):170-3. PubMed ID: 1331304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donated organs as a source of cytomegalovirus (CMV) in renal transplant patients.
    Costa SC; Miranda SR; Alves G; Rossi CL; Figueiredo LT; Costa FF
    Braz J Med Biol Res; 1994 Nov; 27(11):2573-8. PubMed ID: 7549979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.
    Chou SW; Scott KM
    J Clin Microbiol; 1988 Oct; 26(10):2116-9. PubMed ID: 2846638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis.
    Ljungman P; Brand R; Einsele H; Frassoni F; Niederwieser D; Cordonnier C
    Blood; 2003 Dec; 102(13):4255-60. PubMed ID: 12933590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
    Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation.
    Schnitzler MA; Woodward RS; Brennan DC; Spitznagel EL; Dunagan WC; Bailey TC
    Am J Kidney Dis; 1997 Mar; 29(3):428-34. PubMed ID: 9041220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy.
    Preiksaitis JK; Rosno S; Grumet C; Merigan TC
    J Infect Dis; 1983 Jun; 147(6):974-81. PubMed ID: 6304206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of cytomegalovirus infection with renal allograft.
    Betts RF; Freeman RB; Douglas RG; Talley TE; Rundell B
    Kidney Int; 1975 Dec; 8(6):385-92. PubMed ID: 173913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalo and herpes simplex virus infections in renal transplant recipients.
    Wertheim P; Slaterus KW; Geelen JL; van der Noordaa J; Wilmink JM
    Scand J Urol Nephrol Suppl; 1985; 92():5-8. PubMed ID: 3008317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus infections in heart and heart and lung transplant recipients.
    Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA
    J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [incidence of cytomegalovirus infections following transplantation of kidneys from seropositive and seronegative donors].
    Kaden J; Adamczyk G; Eichler C; Strobelt V; Groth J; Janisch W; May G
    Z Urol Nephrol; 1985 May; 78(5):267-71. PubMed ID: 2994321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.